Anneke C. Hesseling
Experienced in Tetanus

Anneke C. Hesseling

Stellenbosch, WC, ZA 
Experienced in Tetanus
Stellenbosch, WC, ZA 
OverviewLocationsClinical Research

Overview

Anneke Hesseling practices in Stellenbosch, South Africa. Ms. Hesseling is rated as an Experienced expert by MediFind in the treatment of Tetanus. Her top areas of expertise are Pulmonary Tuberculosis, Tuberculous Meningitis, HIV/AIDS, and Disseminated Tuberculosis.

Her clinical research consists of co-authoring 326 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Tetanus.

Gender
Female

Locations

Stellenbosch, WC, South Africa
Other Locations
South Africa
Cape Town, WC, South Africa
Port Elizabeth, Wits Health Consortium, Johannesburg And The Tuberculosis And HIV Investigative Network, Durban, ZN, South Africa

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Diagnosis of Tuberculosis Infection in HIV Co-infected Children
Diagnosis of Tuberculosis Infection in HIV Co-infected Children
Enrollment Status: Completed
Publish Date: January 18, 2022
Phase 2, Open-label, Multiple-dose Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Delamanid (OPC-67683) in Pediatric Multidrug-resistant Tuberculosis Patients on Therapy With an Optimized Background Regimen of Anti-tuberculosis Drugs Over a 6-Month Treatment Period
Phase 2, Open-label, Multiple-dose Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Delamanid (OPC-67683) in Pediatric Multidrug-resistant Tuberculosis Patients on Therapy With an Optimized Background Regimen of Anti-tuberculosis Drugs Over a 6-Month Treatment Period
Enrollment Status: Completed
Publish Date: November 23, 2020
Intervention Type: Drug
Study Phase: Phase 2
Phase 1, Open-label, Multiple-dose, and Age De-escalation Trial to Assess the Pharmacokinetics, Safety and Tolerability of Delamanid (OPC 67683) in Pediatric Multidrug-resistant Tuberculosis Patients on Therapy With an Optimized Background Regimen of Anti-tuberculosis Drugs
Phase 1, Open-label, Multiple-dose, and Age De-escalation Trial to Assess the Pharmacokinetics, Safety and Tolerability of Delamanid (OPC 67683) in Pediatric Multidrug-resistant Tuberculosis Patients on Therapy With an Optimized Background Regimen of Anti-tuberculosis Drugs
Enrollment Status: Completed
Publish Date: January 30, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

326 Total Publications

The Effectiveness of Isoniazid Preventive Treatment among Contacts of Multidrug-Resistant Tuberculosis: A Systematic Review and Individual-Participant Meta-Analysis.
The Effectiveness of Isoniazid Preventive Treatment among Contacts of Multidrug-Resistant Tuberculosis: A Systematic Review and Individual-Participant Meta-Analysis.
Journal: American journal of respiratory and critical care medicine
Published: September 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Hesseling's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile